Effect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers

Journal of Clinical Pharmacology

Volumn 42, Issue 2, 2002, Pages 205-214

  Robertson Jr , Philmore ^a   Hellriegel, Edward T ^a   Arora, Sanjay ^a   Nelson, Michael ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C9; MODAFINIL; PLACEBO; WARFARIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME REPRESSION; FEMALE; HUMAN; IN VIVO STUDY; LIVER CELL CULTURE; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STEADY STATE;

ADULT; ANTICOAGULANTS; AREA UNDER CURVE; BENZHYDRYL COMPOUNDS; BIOTRANSFORMATION; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROTHROMBIN TIME; SINGLE-BLIND METHOD; STEREOISOMERISM; WARFARIN;

EID: 0036157193     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700222011120     Document Type: Article

References (21)

1. Long-term efficacy and safety of modafinil (Provigil) for the treatment of excessive daytime sleepiness associated with narcolepsy
2. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
3. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
4. Pharmacokinetic profile of modafinil
5. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers
6. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil
7. Human P450 metabolism of warfarin
8. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
9. Noncompartmental analysis based on statistical moment theory
10. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man
11. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin
12. Cytochrome P4502C9: An enzyme of major importance in human drug metabolism
13. Roles of individual human cytochrome P450 enzymes in the bioactivation of benzo(a)pyrene, 7, 8-dihydroxy-7,8-dyhydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycydic aromatic hydrocarbons
14. Human cytochrome P450 enzymes
15. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes
16. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin
17. The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in health volunteers
18. Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin
19. The effect of multiple doses of donepezil HCI on the pharmacokinetic and pharmacodynamic profile of warfarin
20. Effect of the endothelin-receptor antagonist bosentan on the pharmacokinetics and pharmacodynamics of warfarin